Inventor
ZOOK SCOTT E
US11 patents
⚠️ This page may combine multiple inventors who share the name “ZOOK SCOTT E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUROCRINE BIOSCIENCES INC
6 patentsUS10851104B2Dec 1, 2020
Valbenazine salts and polymorphs thereof
NEUROCRINE BIOSCIENCES INC2 citations71
US10851103B2Dec 1, 2020
Valbenazine salts and polymorphs thereof
NEUROCRINE BIOSCIENCES INC2 citations71
US10844058B2Nov 24, 2020
Valbenazine salts and polymorphs thereof
NEUROCRINE BIOSCIENCES INC2 citations71
US6903106B2Jun 7, 2005
Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
NEUROCRINE BIOSCIENCES INC6 citations67
US7304069B2Dec 4, 2007
Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto
NEUROCRINE BIOSCIENCES INC0 citations48
US7459458B2Dec 2, 2008
Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
NEUROCRINE BIOSCIENCES INC0 citations45
AGOURON PHARMA
5 patentsUS6153757ANov 28, 2000
Metalloproteinase inhibitors and intermediates useful for their preparation
AGOURON PHARMA29 citations91
US6500948B1Dec 31, 2002
Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
AGOURON PHARMA9 citations72
US6849732B2Feb 1, 2005
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
AGOURON PHARMA4 citations61
US6472534B2Oct 29, 2002
Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors
AGOURON PHARMA0 citations50
US6403799B1Jun 11, 2002
Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors
AGOURON PHARMA0 citations50